BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2453540)

  • 1. A patient with lepromatous leprosy and anticytoskeletal antibodies.
    Frey FL; Gottlieb AB; Levis WR
    J Am Acad Dermatol; 1988 May; 18(5 Pt 2):1179-84. PubMed ID: 2453540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticytoskeletal autoantibody development in adjuvant arthritis.
    Franch A; Castellote C; Vilà JL; Vilaró S; Castell M
    J Rheumatol; 1994 Mar; 21(3):489-97. PubMed ID: 7516431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobulin M autoantibody to vimentin intermediate filaments.
    Senecal JL; Rothfield NF; Oliver JM
    J Clin Invest; 1982 Mar; 69(3):716-21. PubMed ID: 7037855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of expression of intermediate filaments during the development of established rat liver cell lines.
    Langbein L; Neupert G
    Acta Histochem; 1986; 80(2):149-58. PubMed ID: 2433884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptotic keratin bodies as autoantigen causing the production of IgM-anti-keratin intermediate filament autoantibodies.
    Grubauer G; Romani N; Kofler H; Stanzl U; Fritsch P; Hintner H
    J Invest Dermatol; 1986 Oct; 87(4):466-71. PubMed ID: 2428883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies to intermediate filaments in experimental infections with Trypanosoma brucei gambiense.
    Anthoons JA; Van Marck EA; Gigase PL
    Z Parasitenkd; 1986; 72(4):443-52. PubMed ID: 3529673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reorganization of keratin intermediate filaments by the drug-induced disruption of microfilaments in cultured human keratinocytes.
    Kitajima Y; Inoue S; Yaoita H
    J Invest Dermatol; 1986 Nov; 87(5):565-9. PubMed ID: 2430025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody to intermediate filaments of the cytoskeleton in the sera of patients with acute malaria.
    Mortazavi-Milani SM; Badakere SS; Holborow EJ
    Clin Exp Immunol; 1984 Jan; 55(1):177-82. PubMed ID: 6362934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2,5-hexanedione aggregates vimentin-, but not keratin-, intermediate filaments of PtK1 cells.
    Durham HD
    Cell Biol Int Rep; 1987 Apr; 11(4):307-18. PubMed ID: 2439214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies to intermediate filaments in sera of patients with Schistosoma mansoni infection.
    Boehme MW; Kataaha PK; Holborow EJ
    Clin Exp Immunol; 1989 Aug; 77(2):230-3. PubMed ID: 2476270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of complement by intermediate filaments of glomerular epithelial cells.
    Linder E; Helin H; Rantala I
    Clin Immunol Immunopathol; 1986 Aug; 40(2):265-75. PubMed ID: 3521974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies to vimentin-type intermediate filament in patients with progressive systemic sclerosis.
    Tsuneda Y; Kitajima Y; Mori S
    J Dermatol; 1988 Apr; 15(2):128-32. PubMed ID: 3049729
    [No Abstract]   [Full Text] [Related]  

  • 13. Altered expression of keratin and vimentin in human retinal pigment epithelial cells in vivo and in vitro.
    Hunt RC; Davis AA
    J Cell Physiol; 1990 Nov; 145(2):187-99. PubMed ID: 1700982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of human tumour cell lines using antibodies to intermediate filaments.
    Moorthi C; Willers I; Ressler B; Goedde HW
    Pathobiology; 1993; 61(3-4):197-9. PubMed ID: 7692876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to cytokeratin filaments in patients with alcoholic liver disease.
    Kurki P; Virtanen I; Lehto VP; Alfthan O; Salaspuro M
    Alcohol Clin Exp Res; 1984; 8(2):212-5. PubMed ID: 6203426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to intermediate filaments in surgical pathology.
    Lehto VP; Miettinen M; Virtanen I
    Arch Geschwulstforsch; 1986; 56(4):283-98. PubMed ID: 2428329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to cytoplasmic intermediate filaments in rheumatic diseases.
    Kurki P; Helve T; Virtanen I
    J Rheumatol; 1983 Aug; 10(4):558-62. PubMed ID: 6352937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral infections and IgM autoantibodies to cytoplasmic intermediate filaments.
    Toh BH; Yildiz A; Sotelo J; Osung O; Holborow EJ; Kanakoudi F; Small JV
    Clin Exp Immunol; 1979 Jul; 37(1):76-82. PubMed ID: 385189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microinjection of monoclonal antibodies specific for one intermediate filament protein in cells containing multiple keratins allow insight into the composition of particular 10 nm filaments.
    Tölle HG; Weber K; Osborn M
    Eur J Cell Biol; 1985 Sep; 38(2):234-44. PubMed ID: 2412818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human upper epidermal cytoplasmic antibodies are directed against keratin intermediate filament proteins.
    Hintner H; Steinert PM; Lawley TJ
    J Clin Invest; 1983 Oct; 72(4):1344-51. PubMed ID: 6195191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.